BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24194261)

  • 1. In vitro inhibitory effect of piperlonguminine isolated from Piper longum on human cytochrome P450 1A2.
    Song M; Hwang JY; Lee MY; Jee JG; Lee YM; Bae JS; Kim JA; Lee SH; Lee S
    Arch Pharm Res; 2014 Aug; 37(8):1063-8. PubMed ID: 24194261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibitory effect of luotonin A on human CYP1A.
    Jahng Y; Kwon OK; Lee S
    Arch Pharm Res; 2012 Dec; 35(12):2199-203. PubMed ID: 23263815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibitory effects of machilin A isolated from Machilus thunbergii on human cytochrome P450 1A and 2B6.
    Kim SJ; You J; Choi HG; Kim JA; Jee JG; Lee S
    Phytomedicine; 2015 Jun; 22(6):615-20. PubMed ID: 26055126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibitory effects of mollugin on CYP1A2 in human liver microsomes.
    Kim H; Choi HK; Jeong TC; Jahng Y; Kim DH; Lee SH; Lee S
    Food Chem Toxicol; 2013 Jan; 51():33-7. PubMed ID: 23000442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of selective inhibitory effects of glycyrol on human CYP 1A1 and 2C9.
    Kim SJ; Kim SJ; Hong M; Choi HG; Kim JA; Lee S
    Xenobiotica; 2016 Oct; 46(10):857-61. PubMed ID: 26750984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomes.
    Paudel S; Jo H; Lee T; Lee S
    Biopharm Drug Dispos; 2023 Oct; 44(5):365-371. PubMed ID: 37448189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6.
    Song M; Hong M; Lee MY; Jee JG; Lee YM; Bae JS; Jeong TC; Lee S
    Food Chem Toxicol; 2013 Sep; 59():549-53. PubMed ID: 23835282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism of 4, 5-dimethoxycanthin-6-one by human liver microsomes and its inhibition on human CYP1A2.
    Miao X; You J; Wang J; Chen Y
    Life Sci; 2017 Dec; 190():46-51. PubMed ID: 28962866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effect of important herbal active constituents on human cytochrome P450 1A2 (CYP1A2) activity.
    Pan Y; Tiong KH; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Ong CE
    Phytomedicine; 2014 Oct; 21(12):1645-50. PubMed ID: 25442272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibitory effects of HYIpro-3-1 on CYP1A2 in human liver microsomes.
    Kim Y; Kim JH; Lee T; Bae JS; Jeong TC; Lee ES; Lee S
    Biopharm Drug Dispos; 2021 Jan; 42(1):35-41. PubMed ID: 33386627
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhang N; Liu J; Chen Z; Dou W
    Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro inhibition of human cytochrome P450 by cudratricusxanthone A.
    Sim J; Choi E; Lee YM; Jeong GS; Lee S
    Food Chem Toxicol; 2015 Jul; 81():171-175. PubMed ID: 25936586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.
    Yang TJ; Sai Y; Krausz KW; Gonzalez FJ; Gelboin HV
    Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    J Pharm Sci; 1998 Dec; 87(12):1502-7. PubMed ID: 10189256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
    Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
    J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2.
    Yang AH; He X; Chen JX; He LN; Jin CH; Wang LL; Zhang FL; An LJ
    Chem Biol Interact; 2015 Jul; 237():133-40. PubMed ID: 26091900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of CYP1A2, CYP2C9, and CYP2D6 by pterostilbene in human liver microsomes.
    Albassam AA; Ahad A; Alsultan A; Yusufoglu HS; Foudah AI; Al-Jenoobi FI
    Pharmazie; 2021 Apr; 76(4):155-158. PubMed ID: 33849700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: impact on in vitro-in vivo extrapolation of drug clearance.
    Wattanachai N; Tassaneeyakul W; Rowland A; Elliot DJ; Bowalgaha K; Knights KM; Miners JO
    Drug Metab Dispos; 2012 May; 40(5):982-9. PubMed ID: 22331994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Inhibition of Bakuchicin Isolated from Psoralea corylifolia on CYP1A in Human Liver Microsomes.
    Kim SJ; Oh HC; Kim YC; Jeong GS; Lee S
    Evid Based Complement Alternat Med; 2016; 2016():5198743. PubMed ID: 26977174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT; Chang YW; Lan SJ; Yeh TK
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.